微创脑科学今日盘中大涨5.27%,引发市场关注。本次股价上涨主要受到以下两大因素的推动:
一是上海市政府印发新政,将设立100亿元生物医药产业并购基金,旨在培育更多具有国际竞争力的医药企业。作为国内领先的微创医疗器械公司,微创脑科学未来或将从中获益,加强并购整合能力。
另一方面,财政部新规定在政府采购中优先采购国产医疗设备,加之有望加快各地推行以旧换新政策,将直接助力微创脑科学等国产医疗器械企业加快进口替代步伐,获取更多订单。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.